Dong-A Pharmaceutical Co Ltd Exports Zydena to Russia

18-Oct-2007

Dong-A Pharmaceutical Co Ltd announced that its subsidiary, Dong-A Pharm-tech, entered into a five-year, US$50 Million contract with Otechestvennye Lekarstva OJSC to market Zydena, Dong-A's erectile dysfunction drug, in Russia.

Under the terms of the agreement, signed on October 15, 2007, Otechestvennye Lekarstva OJSC, one of the largest Russian pharmaceutical firms, will pay both upfront fees and running royalty on sales for the life of the contract.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance